demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 prophylaxis (excluding children)
Janssen AD26 vaccine (JNJ-78436735) ENSEMBLE ...

12 studies excluded by filtering options 0

6484 Sadoff, 2021 110risk of bias not avaialble
6904 HORIZON 1, 0 0310selection pending
6949 Pawlowski, 2021 1130not a RCTrisk of bias not avaialble
8162 Johnson and Johnson, 2021 000selection pending
8295 Sisonke (JNJ South Africa heathworkers), 0 0130selection pending
9173 Sisonke 2 (booster), 2021 1200not a RCTrisk of bias not avaialble
9274 MixNMatch Study, 2021 1100not a RCTrisk of bias not avaialble
9312 Reindl-Schwaighofer, 2021 110risk of bias not avaialble
9343 EPIPHARE (Janssen), 2022 1120not a RCTrisk of bias not avaialble
9361 Husby (janssen), 2021 1120not a RCTrisk of bias not avaialble
9404 Botton (EPI-PHARE), 2022 1120not a RCTrisk of bias not avaialble
9580 Sisonke study (bekker), 2022 000selection pending